MANAR G. HELAL. Empagliflozin attenuates cyclophosphamide-induced hepatotoxicity via targeting Nrf2/HO-1 signaling, oxidative stress, and inflammation. World Journal of Pharmaceutical Sciences, [S. l.], v. 7, n. 11, p. 49–59, 2019. Disponível em: https://wjpsonline.com/index.php/wjps/article/view/empagliflozin-attenuates-cyclophosphamide-induced-hepatotoxicity. Acesso em: 4 feb. 2025.